What clinicians need to know about intranasal esketamine for treatment-resistant depression?
Australas Psychiatry
; 31(6): 841-845, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37961848
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Depressive Disorder, Treatment-Resistant
/
Ketamine
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Australas Psychiatry
Journal subject:
PSIQUIATRIA
Year:
2023
Document type:
Article
Affiliation country:
Australia
Country of publication:
United kingdom